Advertisement

Topics

Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

2014-07-24 14:19:50 | BioPortfolio

Summary

This was a single-center, randomized, double-masked, placebo-controlled, parallel-group, 4-visit, CAE (Controlled Adverse Environment) study lasting approximately 4 weeks. Subjects were randomized to receive loteprednol etabonate ophthalmic suspension, 0.5% or placebo (vehicle of loteprednol etabonate ophthalmic suspension, 0.5%) and instructed to dose bilaterally either TID or QID according to randomization.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Dry Eye

Intervention

loteprednol etabonate ophthalmic suspension, 0.5%, loteprednol etabonate ophthalmic suspension, 0.5%, vehicle

Location

Ophthalmic Research Associates
Andover
Massachusetts
United States
01810

Status

Completed

Source

Bausch & Lomb, Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-24T14:19:50-0400

Clinical Trials [801 Associated Clinical Trials listed on BioPortfolio]

Loteprednol Etabonate Ophthalmic Base Compared to Loteprednol Etabonate Ophthalmic Suspension vs Placebo in an Allergen Challenge

The purpose of this study is to evaluate the efficacy of loteprednol etabonate ophthalmic base, compared to loteprednol etabonate ophthalmic suspension, and vehicle in the prevention of th...

Loteprednol Etabonate and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

This study is to evaluate the safety and efficacy of loteprednol etabonate [LE] and tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in the treatm...

Safety and Efficacy of Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Evaluation of the clinical safety and efficacy of loteprednol etabonate in an ophthalmic base, when compared to vehicle for the treatment of inflammation following cataract surgery.

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)

PubMed Articles [894 Associated PubMed Articles listed on BioPortfolio]

In vitro and ex vivo correlation of drug release from ophthalmic ointments.

In vitro drug release testing and ex vivo transcorneal drug permeation can provide valuable information on the performance of the Q1/Q2 equivalent ointments prior to any animal studies. Good correlati...

Efficacy and Safety of Loteprednol 0.5% and Fluorometholone 0.1% After Strabismus Surgery in Children.

To compare the effects of topical loteprednol and fluorometholone in children who underwent strabismus surgery.

Symmetry of Upper Eyelid Contour After Unilateral Blepharoptosis Repair With a Single-strip Frontalis Suspension Technique.

To analyze the upper eyelid contour of patients with unilateral congenital ptosis who underwent single-strip frontalis suspension.

Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation.

Nepafenac is a nonsteroidal anti-inflammatory drug (NSAID), currently only available as 0.1% ophthalmic suspension (Nevanac®). This study utilized hydroxypropyl-β-cyclodextrin (HPBCD) to increase th...

Ophthalmic Plastic Surgery in Patients 100 Years and Older.

The centenarian population is growing and ophthalmic plastic surgeons are providing care to an increasing number of elderly patients. Outcomes of centenarians have not been previously studied in the o...

Medical and Biotech [MESH] Definitions

An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.

A sensory branch of the trigeminal (5th cranial) nerve. The ophthalmic nerve carries general afferents from the superficial division of the face including the eyeball, conjunctiva, upper eyelid, upper nose, nasal mucosa, and scalp.

Application of pharmaceutically active agents on the tissues of the EYE.

A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.

One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

More From BioPortfolio on "Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial